These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 9702939)

  • 21. E-cadherin and catenins in early squamous cervical carcinoma.
    Van de Putte G; Kristensen GB; Baekelandt M; Lie AK; Holm R
    Gynecol Oncol; 2004 Aug; 94(2):521-7. PubMed ID: 15297198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of E-cadherin, cadherin-11, alpha-, beta- and gamma-catenins in nephroblastomas: relationship with clinicopathological parameters, prognostic factors and outcome.
    Ramburan A; Hadley GP; Govender D
    Pathology; 2006 Feb; 38(1):39-44. PubMed ID: 16484007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
    Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
    Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast.
    Gillett CE; Miles DW; Ryder K; Skilton D; Liebman RD; Springall RJ; Barnes DM; Hanby AM
    J Pathol; 2001 Apr; 193(4):433-41. PubMed ID: 11276001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expression of E-cadherin and catenins in colorectal tumours from familial adenomatous polyposis patients.
    El-Bahrawy MA; Talbot IC; Poulsom R; Jeffery R; Alison MR
    J Pathol; 2002 Sep; 198(1):69-76. PubMed ID: 12210065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlation of E-cadherin, beta-catenin and gamma-catenin gene expression with the invasion and metastasis of gastric carcinoma].
    Wang CX; Chen J; Yang Z; Song W; Du ZL; Li ZH
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1198-201. PubMed ID: 14625188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant.
    Rocha AS; Soares P; Seruca R; Máximo V; Matias-Guiu X; Cameselle-Teijeiro J; Sobrinho-Simões M
    J Pathol; 2001 Jul; 194(3):358-66. PubMed ID: 11439369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions.
    Davidson B; Berner A; Nesland JM; Risberg B; Berner HS; Tropè CG; Kristensen GB; Bryne M; Ann Florenes V
    J Pathol; 2000 Dec; 192(4):460-9. PubMed ID: 11113863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The expression and prognostic value of alpha-, beta- and gamma-catenins in renal cell carcinoma.
    Aaltomaa S; Lipponen P; Kärjä V; Lundstedt S; Lappi J; Kosma VM
    Anticancer Res; 2004; 24(4):2407-13. PubMed ID: 15330191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. E-cadherin and alpha-, beta- and gamma-catenin expression in prostate cancers: correlation with tumour invasion.
    Morita N; Uemura H; Tsumatani K; Cho M; Hirao Y; Okajima E; Konishi N; Hiasa Y
    Br J Cancer; 1999 Apr; 79(11-12):1879-83. PubMed ID: 10206308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells.
    Sommers CL; Gelmann EP; Kemler R; Cowin P; Byers SW
    Cancer Res; 1994 Jul; 54(13):3544-52. PubMed ID: 8012979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction in membranous expression of beta-catenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer.
    Ramesh S; Nash J; McCulloch PG
    Br J Cancer; 1999 Dec; 81(8):1392-7. PubMed ID: 10604738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: correlation with disease progression and dedifferentiation.
    Bailey T; Biddlestone L; Shepherd N; Barr H; Warner P; Jankowski J
    Am J Pathol; 1998 Jan; 152(1):135-44. PubMed ID: 9422531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta- and gamma-catenin expression in oral squamous cell carcinomas.
    Lo Muzio L; Staibano S; Pannone G; Grieco M; Mignogna MD; Cerrato A; Testa NF; De Rosa G
    Anticancer Res; 1999; 19(5B):3817-26. PubMed ID: 10628318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the E-cadherin-catenin complex in lung neuroendocrine tumours.
    Clavel CE; Nollet F; Berx G; Tejpar S; Nawrocki-Raby B; Kaplan HH; van Roy FM; Birembaut PL
    J Pathol; 2001 May; 194(1):20-6. PubMed ID: 11329137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caspase-dependent cleavage of cadherins and catenins during osteoblast apoptosis.
    Hunter I; McGregor D; Robins SP
    J Bone Miner Res; 2001 Mar; 16(3):466-77. PubMed ID: 11277264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of E-cadherin, alpha- and beta-catenins in patients with pancreatic adenocarcinoma.
    Joo YE; Rew JS; Park CS; Kim SJ
    Pancreatology; 2002; 2(2):129-37. PubMed ID: 12123093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the E-cadherin-catenin complexes in pancreatic carcinoma cell lines.
    El-Hariry I; Jordinson M; Lemoine N; Pignatelli M
    J Pathol; 1999 Jun; 188(2):155-62. PubMed ID: 10398158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant E-cadherin and alpha-catenin expression in prostate cancer: correlation with patient survival.
    Richmond PJ; Karayiannakis AJ; Nagafuchi A; Kaisary AV; Pignatelli M
    Cancer Res; 1997 Aug; 57(15):3189-93. PubMed ID: 9242448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer.
    Lim SC; Lee MS
    Oncol Rep; 2002; 9(5):915-28. PubMed ID: 12168049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.